FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
Feigal
D
D
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents